As the global market continues to integrate, Chinese enterprises are entering a golden era of “going overseas”(International expansion). From Europe and America to Southeast Asia, every market holds boundless opportunities. […]
In response to the growing trend of localisation requirements in China’s MedTech market, Fiducia Strategy Advisory (FSA) had the great honor to collaborate with Switzerland Global Enterprise (S-GE), to co-author […]
The Chinese medical industry is continuously improving with residents’ rising health awareness, population aging and the development of technologies. In the past year, Fiducia Strategy Advisory has provided support to […]
In recent years mergers and acquisitions have become an important topic for Euro-Sino cooperation to co-share resources and better expand markets. Fiducia Strategy Advisory (FSA) has achieved good success in […]
China is more affluent and innovative than ever, but also more complex and competitive. In this new reality that we call “China 2.0”, foreign businesses are under intense pressure to […]
